Once-Yearly Lenacapavir for PrEP: Model-Informed Dose Determination and Phase 3 Trial Design

Conference Reports for NATAP

Conference on Retroviruses
and Opportunistic Infections
Denver, CO 80202, United States
February 22 - 25, 2026


Once-Yearly Lenacapavir for PrEP: Model-Informed Dose Determination and Phase 3 Trial Design

	CROI 2026 Feb 22-25 Denver Emma Hughes1, Vamshi Jogiraju1, Jenna Yager1, Moupali Das1, Chris Carter1, Renu Singh1, Curtis Johnston1 1Gilead Sciences, Inc., Foster City, CA, USA